NCT03975790View on ClinicalTrials.gov

Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX

CompletedOBSERVATIONAL
Enrollment

479

Participants

Timeline

Start Date

May 29, 2018

Primary Completion Date

October 2, 2018

Study Completion Date

October 2, 2018

Conditions
Rheumatoid Arthritis
Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY